Shares of Masimo are trading down 1.6% to $34.03 today on above average volume. Approximately 663,000 shares have changed hands today vs. average 30-day volume of 345,000 shares. Spikes in volume can validate a breakout or signify a potential turning point.
Masimo Corporation designs, develops and licenses medical signal processing and sensor technology for the noninvasive monitoring of physiological parameters. The Company's first products are designed to improve the effectiveness of pulse oximetry by overcoming the inability of current monitors to precisely measure the levels of arterial blood oxygen saturation and low arterial blood flow.
Over the past year, Masimo has traded in a range of $17.62 to $35.39 and is now at $34.03, 93% above that low. The 200-day and 50-day moving averages have moved 0.58% higher and 0.84% higher over the past week, respectively.
Masimo (NASDAQ:MASI) is currently priced 12.9% above its average consensus analyst price target of $29.65. Masimo shares have support at the 50-day moving average (MA) of $32.66 and additional support at the 200-day MA of $26.53.